The US is one step closer to having a single-dose coronavirus vaccine after Johnson & Johnson asked the Food and Drug Administration (FDA) to authorize its vaccine on Thursday night. Johnson & Johnson has asked the FDA to authorize its single-shot coronavirus vaccine. The US has an agreement to buy 100 million doses of J&J's vaccine for $1 billion, making each dose priced around $10. The US has an agreement to buy 100 million doses of J&J's vaccine for $1 billion, and the option of purchasing an additional 200 million doses. Because J&J's vaccine requires just one dose, 100 million doses would get twice as many people full protection as 100 million doses of either Pfizer's or Moderna's vaccine.

Source: Daily Mail February 04, 2021 23:22 UTC